Trivarx Limited has released a press release.
CRO Engaged to Advance Stabl-Im Phase 1 Trial
Earlier from Trivarx
- March 2026 Quarterly Activities Report and Appendix 4C
- Dr Danielle Meyrick appointed as CEO
- Appendix 4D & Half-Year Financial Report to 31 December 2025
- December 2025 Quarterly Activities Report and Appendix 4C